gidazepam gidazepam gidazepam, also known as hydazepam or hidazepam, is a drug which is an atypical benzodiazepine derivative, developed in the soviet union. it is a selectively anxiolytic benzodiazepine. it also has therapeutic value in the management of certain cardiovascular disorders. gidazepamclinical datatrade namesgidazepam icroutes ofadministrationorallegal statuslegal status ca: schedule iv us: unscheduled rx-only (ua) pharmacokinetic datametabolismhepaticelimination half-life86,7 hours(for active metabolite)excretionrenalidentifiers iupac name 2-(9-bromo-3-oxo-6-phenyl-2,5-diazabicycloundeca-5,8,10,12-tetraen-2-yl)acetohydrazide cas number129186-29-4pubchem cid121919drugbank? nchemspider108764 yuniixmj87i93y9comptox dashboard (epa)dtxsid00156091 chemical and physical dataformulac17h15brn4o2molar mass387.2 g·mol−13d model (jsmol)interactive image smiles brc1=cc2=c(c=c1)n(cc(nn)=o)c(cn=c2c3=cc=cc=c3)=o inchi inchi=1s/c17h15brn4o2/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)20-9-16(24)22(14)10-15(23)21-19/h1-8h,9-10,19h2,(h,21,23) ykey:xlgcmzlsexrbsg-uhfffaoysa-n y ny (what is this?) (verify) gidazepam is a prodrug for its active metabolite 7-bromo-2,3-dihydro-5-phenyl-1h-1,4-benzodiazepin-2-one (desalkylgidazepam or bromo-nordazepam). it is used as an antianxiety drug. its anxiolytic effects can take several hours to manifest after dosing however, as it is the active metabolite which primarily gives the anxiolytic effects, and gidazepam's half-life is among the longest of all gaba-ergic agonists. gidazepam active metabolite (desalkylgidazepam), responsible for its therapeutic effects